CKD Progression Risk Up With Increasing Albuminuria in Normal Range
By Elana Gotkine HealthDay Reporter
MONDAY, April 1, 2024 -- For people with chronic kidney disease (CKD) and normoalbuminuria, the risk for CKD progression increases with higher levels of albuminuria, according to a study published online April 2 in the Annals of Internal Medicine.
Ashish Verma, M.B., B.S., from the Boston University Chobanian & Avedisian School of Medicine, and colleagues estimated the increase in the cumulative incidence of CKD progression with higher baseline levels of albuminuria among persons with CKD who had normoalbuminuria (<30 mg/g) in a multicenter prospective study. Data were included for 1,629 participants meeting criteria from the Chronic Renal Insufficiency Cohort study with CKD and a urine albumin-creatinine ratio (UACR) <30 mg/g.
The researchers found that 182 of the participants experienced CKD progression during a median follow-up of 9.8 years. For UACR levels of 0 to <5, 5 to <15, and ≥15 mg/g, the 10-year adjusted cumulative incidences of CKD progression were 8.7, 11.5, and 19.5 percent, respectively. The absolute risk differences were 7.9 and 10.7 percent comparing persons with UACR ≥15 mg/g to those with UACR of 5 to <15 and 0 to <5 mg/g, respectively. There was a linear increase observed in 10-year adjusted cumulative incidence based on baseline UACR levels.
"These findings underscore the need for future studies to determine the optimal threshold for initiating treatment with antiproteinuric agents and whether the further reduction in albuminuria may improve adverse clinical outcomes in persons with CKD who have normoalbuminuria," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females...
Concussions in Children Less Likely to Be Related to Sport
FRIDAY, July 19, 2024 -- For children aged 5 through 12 years with concussion, recreation-related concussion (RRC) and non-sport or recreation-related concussion (non-SRRC) occur...
Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer
FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.